Nobilis Says Remains Uncertain as to When it Will be Able to Finalize Financial Statements

Nobilis Health Corp. (NYSE MKT: HLTH) previously announced that due to its new auditor having not completed their quarterly review procedures, it would not be in a position, by the filing deadline, to file its unaudited interim financial statements for the three and nine months ended September 30, 2015 (the "Financial Statements") and the related management's discussion and analysis ("MD&A") and related CEO and CFO certificates. It remains uncertain as to when the Company will be able to finalize its Financial Statements and related disclosures.As previously announced, the Company continues to work with its auditor to resolve certain non-cash accounting matters and opening balance sheet valuations related to business combinations.The Company has made and the Ontario Securities Commission, as principal regulator for the Company, has approved an application under National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203") requesting that a management cease trade order be imposed in respect of this late filing rather than an issuer cease trade order. The issuance of a management cease trade order generally does not affect the ability of persons who have not been directors, officers or See full press release